MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 57 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,763,150 | -35.9% | 6,004,833 | -8.3% | 0.00% | -50.0% |
| Q2 2023 | $44,838,264 | -55.2% | 6,545,732 | -49.0% | 0.00% | -20.0% |
| Q1 2023 | $100,039,788 | +111.4% | 12,842,078 | +106.5% | 0.01% | 0.0% |
| Q4 2022 | $47,314,856 | -6.7% | 6,217,458 | +0.2% | 0.01% | 0.0% |
| Q3 2022 | $50,695,000 | -15.6% | 6,204,974 | -0.1% | 0.01% | -16.7% |
| Q2 2022 | $60,075,000 | -38.7% | 6,212,544 | -11.2% | 0.01% | -25.0% |
| Q1 2022 | $98,064,000 | -31.2% | 6,994,548 | +0.3% | 0.01% | -27.3% |
| Q4 2021 | $142,447,000 | -6.8% | 6,975,887 | +0.3% | 0.01% | -8.3% |
| Q3 2021 | $152,879,000 | +63.4% | 6,957,284 | +61.3% | 0.01% | +71.4% |
| Q2 2021 | $93,549,000 | – | 4,312,259 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $33,422,000 | 5.35% |
| Cormorant Asset Management, LP | 3,193,973 | $69,550,000 | 2.36% |
| NEA Management Company, LLC | 7,703,205 | $174,863,000 | 2.28% |
| Octagon Capital Advisors LP | 238,045 | $5,404,000 | 1.12% |
| Avoro Capital Advisors LLC | 3,311,434 | $62,153,000 | 1.08% |
| Alphabet Inc. | 1,464,015 | $33,233,000 | 0.68% |
| Logos Global Management LP | 300,000 | $6,810,000 | 0.57% |
| Casdin Capital, LLC | 960,883 | $21,812,000 | 0.55% |
| RTW INVESTMENTS, LP | 1,214,572 | $25,228,000 | 0.38% |
| Monashee Investment Management LLC | 120,000 | $2,724,000 | 0.33% |